Division of Pediatric Neurology, Department of Pediatrics, Inselspital, University of Berne, Berne, Switzerland.
Epilepsia. 2012 Dec;53(12):2128-34. doi: 10.1111/j.1528-1167.2012.03676.x. Epub 2012 Sep 27.
Sodium channel gene aberrations are associated with a wide range of seizure disorders, particularly Dravet syndrome. They usually consist of missense or truncating gene mutations or deletions. Duplications involving multiple genes encoding for different sodium channels are not widely known. This article summarizes the clinical, radiologic, and genetic features of patients with 2q24 duplication involving the sodium channel gene cluster.
A systematic review of the literature and report of two cases.
Nine individuals with 2q24 duplication involving the sodium channel gene cluster are described (seven female, two male). All presented with severe seizures refractory to anticonvulsant drugs. Seizure onset was in the neonatal period in eight patients with SCN1A-involvement, in infancy in one patient with SCN2A and SCN3A, but no SCN1A involvement. Seizure activity decreased and eventually stopped at 5-20 months of age. Seizures recurred at the age of 3 years in the patient with SCN2A and SCN3A, but no SCN1A involvement. Eight patients had a poor neurodevelopmental outcome despite seizure freedom.
This article describes a distinct seizure disorder associated with a duplication of the sodium gene cluster on 2q24 described in otherwise healthy neonates and infants with severe, anticonvulsant refractory seizures and poor developmental outcome despite seizure freedom occurring at the age of 5-20 months.
钠通道基因突变与广泛的癫痫发作障碍有关,特别是德雷夫特综合征。它们通常由错义或截断基因突变或缺失组成。涉及多个编码不同钠通道的基因的重复并不广为人知。本文总结了涉及钠通道基因簇的 2q24 重复的患者的临床、放射学和遗传学特征。
对文献进行系统回顾和报告两例病例。
描述了 9 例涉及钠通道基因簇的 2q24 重复患者(7 名女性,2 名男性)。所有患者均表现为对抗癫痫药物难治性严重癫痫发作。8 例 SCN1A 受累患者的癫痫发作始于新生儿期,1 例 SCN2A 和 SCN3A 受累患者的癫痫发作始于婴儿期,但无 SCN1A 受累。癫痫发作活动在 5-20 个月时减少并最终停止。在 SCN2A 和 SCN3A 但无 SCN1A 受累的患者中,癫痫发作在 3 岁时再次发作。尽管癫痫发作得到控制,但 8 名患者的神经发育结局较差。
本文描述了一种与 2q24 上钠基因簇重复相关的独特癫痫发作障碍,涉及到健康新生儿和婴儿,这些婴儿表现为严重的、对抗癫痫药物耐药的癫痫发作,尽管在 5-20 个月时癫痫发作得到控制,但神经发育结局较差。